Jordan to Showcase New Pharmaceutical Facilities and Tracking System at Upcoming EU Summit

Amman:Jordan is set to highlight three major investments in the pharmaceutical and healthcare technology sectors at the forthcoming Jordan-EU Investment Conference to be held at the Dead Sea next Thursday. The initiatives aim to address gaps in regional manufacturing of biosimilars and oncology drugs, as well as to digitize the national pharmaceutical supply chain.

According to Jordan News Agency, the conference will be held under Royal patronage and attended by European Commission President Ursula von der Leyen, along with over 700 international business leaders and financiers. The event will focus on three high-tech health sector opportunities.

The first project is a Biosimilars Fill-and-Finish Manufacturing Plant designed to meet Good Manufacturing Practice (GMP) standards. This facility will include advanced aseptic filling, lyophilization, and quality control labs, specifically targeting the fill-and-finish bottlenecks in the Middle East and North Africa (MENA) region.

The second initiative is an Oncology Active Pharmaceutical Ingredients (APIs) Plant, which will be located within a Jordanian development zone. This plant will initially offer a portfolio of six oncology API molecules, with an annual capacity of 40,000 to 60,000 kilograms, supported by advanced processing units.

The third project is the Pharmaceutical Track and Trace System (PTTS), a digital platform intended to centralize the tracking of medications across Jordan's supply chain. This system will improve market transparency and regulatory oversight by logging serialized medication data.